Opinion
Video
Author(s):
Panelists discuss how their clinical experience with continuous subcutaneous infusion therapies has informed their approach to integrating these treatments into existing regimens, including strategies for medication adjustments and valuable lessons from European clinical practice that could benefit US clinicians.
Video content above is prompted by the following:
Clinical Experience With Infusion Systems
Experience with Continuous Subcutaneous Apomorphine Infusion (CSAI) and Other Infusions:
Incorporation Into Existing Treatment Plans:
Adjusting Levodopa and Other Medications:
Lessons From European CSAI Experience:
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.